Authors: Wiseman, GA White, CA Sparks, RB Erwin, WD Podoloff, DA Lamonica, D Bartlett, NL Parker, JA Dunn, WL Spies, SM Belanger, R Witzig, TE Leigh, BR

Citation: Ga. Wiseman et al., Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin (TM) radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma, CR R ONC H, 39(1-2), 2001, pp. 181-194

Authors: DeNardo, SJ Burke, PA Leigh, BR O'Donnell, RT Miers, LA Kroger, LA Goodman, SL Matzku, S Jonczyk, A Lamborn, KR DeNardo, GL

Citation: Sj. Denardo et al., Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy, CANC BIO R, 15(1), 2000, pp. 71-79

Authors: Chou, RH Wilder, RB Ji, M Ryu, JK Leigh, BR Earle, JD Doggett, RLS Kubo, HD Roach, M White, RWD

Citation: Rh. Chou et al., Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy, INT J RAD O, 47(1), 2000, pp. 115-119

Authors: O'Donnell, RT Leigh, BR Christensen, SD Goldstein, DS Kukis, DL Shen, S Yuan, A DeNardo, DA Kroger, LA Denardo, GL

Citation: Rt. O'Donnell et al., Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associatedlymphoma, CANC BIO R, 14(3), 1999, pp. 167-176

Authors: Leigh, BR Burke, PA Hong, AM O'Donnell, RT Howell, LP Miers, LA DeNardo, GL DeNardo, SJ

Citation: Br. Leigh et al., Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy, CANC BIO R, 14(2), 1999, pp. 113-119

Authors: Leigh, BR Gandara, DR

Citation: Br. Leigh et Dr. Gandara, Chemoradiation for locally advanced, unresectable NSCLC - New standard of care, emerging strategies - The Gordon/Vokes article reviewed, ONCOLOGY-NY, 13(8), 1999, pp. 1088